Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole.
Van Calster B, Van Ginderachter J, Vlasselaer J, Van de Putte G, Berteloot P, Timmerman D, Depypere H, Blomme C, Vlaemynck G, De Jonge E, Van den Broecke R, Vergote I, Amant F, Van Huffel S, Neven P.
Van Calster B, et al. Among authors: van huffel s, van ginderachter j, van den broecke r, van de putte g.
Menopause. 2011 Feb;18(2):224-9. doi: 10.1097/gme.0b013e3181eb9f14.
Menopause. 2011.
PMID: 20881891
Clinical Trial.